학술논문
Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma
Document Type
Article
Author
Source
In: Oncogene . (Oncogene, 22 March 2024, 43(13):962-975)
Subject
Language
English
ISSN
14765594
09509232
09509232